9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

Clinical Study of YS110 in Patients With Malignant Pleural Mesothelioma

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > Clinical Study of YS110 in Patients With Malignant Pleural Mesothelioma

Clinical Study of YS110 in Patients With Malignant Pleural Mesothelioma

Estimated reading time: < 1 min

Condition: Malignant Pleural Mesothelioma

Estimated Enrollment: 48

Gender: All

Min Age: 20 Years

Age Group: Adult, Older Adult

Current Status: Active, not recruiting

Study Results: No Results Available

Outcome Measures: Status of onset of Dose Limiting Toxicity (DLT),  Disease Control Rate (DCR),  Progression Free Survival (PFS), Response Rate (RR)

Interventions: YS110,

Phase:

Study Type: Interventional

Study Design: Intervention Model: Single Group Assignment, Masking: None (Open Label), Primary Purpose: Treatment,

Primary Completion Date: December 2020

Completion Date: December 2020

Last  Posted Date: April 1, 2019

Location: Research Site, Multiple Locations, Japan

Website Link: https://ClinicalTrials.gov/show/NCT03177668

Was this article helpful?
Dislike 0